Tisk…

BIOV2219

BIOV2219-50EA 7780 CZK
BIOV2219-50 BIOV2219-10
BIOV2219
An anti-arthritic drug that inhibits various leukocyte activation pathways at multiple sites. Inhibits release of inflammatory mediators from human basophils, pulmonary mast cells and macrophages. Efficient inducer of mitochondrial membrane permeability transition through the inhibition of mitochondrial thioredoxin reductase (TrxR).

  • Inhibits human neutrophil 5-lipoxygenase
  • Inhibits IκB kinase (IKK) by modifying Cys179 of the IKKß subunit

Upozornení: For research use only. Not for use in humans.
Objednat

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Více About VWR